Carregant...
Single-Arm Phase II Cancer Survival Trial Designs
The current practice for designing single-arm phase II trials with time-to-event endpoints is limited to using either a maximum likelihood estimate test under the exponential model or a naive approach based on dichotomizing the event time at a landmark time point. A trial designed under the exponent...
Guardat en:
| Publicat a: | J Biopharm Stat |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223772/ https://ncbi.nlm.nih.gov/pubmed/26098141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2015.1052494 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|